Quest Diagnostics Inc (DGX): Capital Expenditures
$527.00M
Year ended 2025-12-31
$554.00M
Trailing 12 months to 2026-06-30
+9.3%
3-year compound annual growth
+4.7%
5-year compound annual growth
+7.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $527.00M | +24.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $425.00M | +4.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $408.00M | +1.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $404.00M | +0.2% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $403.00M | -3.6% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $418.00M | +4.5% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $400.00M | +4.4% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $383.00M | +52.0% | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | $252.00M | -14.0% | 2020-02-20, From 2017-01-01 |
| 2016-12-31 | $293.00M | +11.4% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $263.00M | -14.6% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $308.00M | +33.3% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $231.00M | +26.9% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $182.00M | +13.0% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $161.00M | -21.6% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $205.40M | +23.0% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $166.93M | -21.5% | 2012-02-16, From 2009-01-01 |
| 2008-12-31 | $212.68M | -2.9% | 2011-02-16, From 2008-01-01 |
| 2007-12-31 | $219.10M | n/a | 2010-02-17, From 2007-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $527.00M | +24.0% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $434.50M | -11.3% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $25.20M | -1.2% |
| Natera, Inc. (NTRA) | 2025-12-31 | $106.19M | +59.9% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗